{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:16:14Z","timestamp":1790435774112,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiogenesis and inflammation are implicated in aortic aneurysm and atherosclerosis and regulated by angiopoietin-2 (Angpt2). The effect of Angpt2 administration on experimental aortic aneurysm and atherosclerosis was examined. Six-month-old male apolipoprotein E deficient (ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>) mice were infused with angiotensin II (AngII) and administered subcutaneous human Fc-protein (control) or recombinant Angpt2 (rAngpt2) over 14 days. Administration of rAngpt2 significantly inhibited AngII-induced aortic dilatation and rupture of the suprarenal aorta (SRA), and development of atherosclerosis within the aortic arch. These effects were blood pressure and plasma lipoprotein independent and associated with Tie2 activation and down-regulation of monocyte chemotactic protein-1 (MCP-1) within the SRA. Plasma concentrations of MCP-1 and interleukin-6 were significantly lower in mice receiving rAngpt2. Immunostaining for the monocyte\/macrophage marker MOMA-2 and the angiogenesis marker CD31 within the SRA were less in mice receiving rAngpt2 than controls. The percentage of inflammatory (Ly6C<jats:sup>hi<\/jats:sup>) monocytes within the bone marrow was increased while that in peripheral blood was decreased by rAngpt2 administration. In conclusion, administration of rAngpt2 attenuated angiotensin II-induced aortic aneurysm and atherosclerosis in ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice associated with reduced aortic inflammation and angiogenesis. Up-regulation of Angpt2 may have potential therapeutic value in patients with aortic aneurysm and atherosclerosis.<\/jats:p>","DOI":"10.1038\/srep35190","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T09:47:11Z","timestamp":1477043231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Angiopoietin-2 attenuates angiotensin II-induced aortic aneurysm and atherosclerosis in apolipoprotein E-deficient mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Hongyou","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Trollope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kinobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Golledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"BFsrep35190_CR1","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","volume":"26","author":"J Golledge","year":"2006","unstructured":"Golledge, J., Muller, J., Daugherty, A. & Norman, P. Abdominal aortic aneurysm: Pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 26, 2605\u20132613 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep35190_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2011.03.006","volume":"217","author":"J Golledge","year":"2011","unstructured":"Golledge, J. & Norman, P. E. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 217, 57\u201363 (2011).","journal-title":"Atherosclerosis."},{"key":"BFsrep35190_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/01.CIR.85.1.205","volume":"85","author":"D Reed","year":"1992","unstructured":"Reed, D., Reed, C., Stemmermann, G. & Hayashi, T. Are aortic aneurysms caused by atherosclerosis? Circulation. 85, 205\u2013211 (1992).","journal-title":"Circulation."},{"key":"BFsrep35190_CR4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/ATVBAHA.110.206573","volume":"30","author":"J Golledge","year":"2010","unstructured":"Golledge, J. & Norman, P. E. Atherosclerosis and abdominal aortic aneurysm: Cause, response, or common risk factors? Arterioscler. Thromb. Vasc. Biol. 30, 1075\u20131077 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep35190_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm0206-171","volume":"12","author":"BA Imhof","year":"2006","unstructured":"Imhof, B. A. & Aurrand-Lions, M. Angiogenesis and inflammation face off. Nat. Med. 12, 171\u2013172 (2006).","journal-title":"Nat. Med."},{"key":"BFsrep35190_CR6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein e-deficient mice. J. Clin. Invest. 105, 1605\u20131612 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFsrep35190_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","volume":"63","author":"AW Armstrong","year":"2011","unstructured":"Armstrong, A. W., Voyles, S. V., Armstrong, E. J., Fuller, E. N. & Rutledge, J. C. Angiogenesis and oxidative stress: Common mechanisms linking psoriasis with atherosclerosis. J. Dermatol. Sci. 63, 1\u20139 (2011).","journal-title":"J. Dermatol. Sci."},{"key":"BFsrep35190_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1196\/annals.1383.007","volume":"1085","author":"E Choke","year":"2006","unstructured":"Choke, E. et al. Increased angiogenesis at the site of abdominal aortic aneurysm rupture. Ann. N Y Acad. Sci. 1085, 315\u2013319 (2006).","journal-title":"Ann. N Y Acad. Sci."},{"key":"BFsrep35190_CR9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1078-5884(96)80183-3","volume":"11","author":"MM Thompson","year":"1996","unstructured":"Thompson, M. M., Jones, L., Nasim, A., Sayers, R. D. & Bell, P. R. Angiogenesis in abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 11, 464\u2013469 (1996).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFsrep35190_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin, H. G., Koh, G. Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system. Nat. Rev. Mol. Cell. Biol. 10, 165\u2013177 (2009).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"BFsrep35190_CR11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","volume":"27","author":"U Fiedler","year":"2006","unstructured":"Fiedler, U. & Augustin, H. G. Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol. 27, 552\u2013558 (2006).","journal-title":"Trends Immunol."},{"key":"BFsrep35190_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for tie2 that disrupts in vivo angiogenesis. Science. 277, 55\u201360 (1997).","journal-title":"Science."},{"key":"BFsrep35190_CR13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ijcard.2012.03.120","volume":"167","author":"J Golledge","year":"2013","unstructured":"Golledge, J., Clancy, P., Yeap, B. B., Hankey, G. J. & Norman, P. E. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int. J. Cardiol. 167, 1159\u20131163 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFsrep35190_CR14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","volume":"134","author":"A Daugherty","year":"2001","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Antagonism of at2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol. 134, 865\u2013870 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep35190_CR15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.atherosclerosis.2005.05.016","volume":"184","author":"N Ayabe","year":"2006","unstructured":"Ayabe, N. et al. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis. 184, 312\u2013321 (2006).","journal-title":"Atherosclerosis."},{"key":"BFsrep35190_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler, U. et al. Angiopoietin-2 sensitizes endothelial cells to TNF-\u03b1 and has a crucial role in the induction of inflammation. Nat. Med. 12, 235\u2013239 (2006).","journal-title":"Nat. Med."},{"key":"BFsrep35190_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/rp.59.1.51","volume":"59","author":"KG Peters","year":"2004","unstructured":"Peters, K. G. et al. Functional significance of tie2 signaling in the adult vasculature. Recent Prog. Horm. Res. 59, 51\u201371 (2004).","journal-title":"Recent Prog. Horm. Res."},{"key":"BFsrep35190_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/293641","volume":"2012","author":"M Murakami","year":"2012","unstructured":"Murakami, M. Signaling required for blood vessel maintenance: Molecular basis and pathological manifestations. Int. J. Vasc. Med. 2012, 1\u201315 (2012).","journal-title":"Int. J. Vasc. Med."},{"key":"BFsrep35190_CR19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1242\/jcs.01653","volume":"118","author":"M Scharpfenecker","year":"2005","unstructured":"Scharpfenecker, M., Fiedler, U., Reiss, Y. & Augustin, H. G. The tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell. Sci. 118, 771\u2013780 (2005).","journal-title":"J. Cell. Sci."},{"key":"BFsrep35190_CR20","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","volume":"29","author":"HT Yuan","year":"2009","unstructured":"Yuan, H. T., Khankin, E. V., Karumanchi, S. A. & Parikh, S. M. Angiopoietin 2 is a partial agonist\/antagonist of tie2 signaling in the endothelium. Mol. Cell. Biol. 29, 2011\u20132022 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"BFsrep35190_CR21","doi-asserted-by":"crossref","first-page":"a006550","DOI":"10.1101\/cshperspect.a006650","volume":"2","author":"G Thurston","year":"2012","unstructured":"Thurston, G. & Daly, C. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb. Perspect. Med. 2, a006550 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFsrep35190_CR22","doi-asserted-by":"crossref","first-page":"15491","DOI":"10.1073\/pnas.0607538103","volume":"103","author":"C Daly","year":"2006","unstructured":"Daly, C. et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc. Natl. Acad. Sci. USA. 103, 15491\u201315496 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFsrep35190_CR23","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-06-4056","volume":"67","author":"Y Cao","year":"2007","unstructured":"Cao, Y. et al. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res. 67, 3835\u20133844 (2007).","journal-title":"Cancer Res."},{"key":"BFsrep35190_CR24","doi-asserted-by":"crossref","first-page":"H1003","DOI":"10.1152\/ajpheart.00866.2011","volume":"302","author":"JX Chen","year":"2012","unstructured":"Chen, J. X., Zeng, H., Reese, J., Aschner, J. L. & Meyrick, B. Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db\/db mouse model. Am. J. Physiol. Heart Circ. Physiol. 302, H1003\u2013H1012 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFsrep35190_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bjoms.2008.06.008","volume":"47","author":"HH Chen","year":"2009","unstructured":"Chen, H. H., Shi, Z. J., Wang, S. Q. & Wu, Q. L. The effects of angiopoietin-2 on the growth of tongue carcinoma. Br. J. Oral Maxillofac. Surg. 47, 14\u201319 (2009).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"BFsrep35190_CR26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.105.086553","volume":"314","author":"F Roviezzo","year":"2005","unstructured":"Roviezzo, F. et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J. Pharmacol. Exp. Ther. 314, 738\u2013744 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep35190_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","volume":"35","author":"Y Suzuki","year":"2003","unstructured":"Suzuki, Y. et al. Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881\u2013900 (2003).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFsrep35190_CR28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cvr\/cvr080","volume":"91","author":"H Kaneko","year":"2011","unstructured":"Kaneko, H. et al. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. Cardiovasc. Res. 91, 358\u2013367 (2011).","journal-title":"Cardiovasc. Res."},{"key":"BFsrep35190_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jvs.2010.02.015","volume":"52","author":"E Choke","year":"2010","unstructured":"Choke, E. et al. Vascular endothelial growth factor enhances angiotensin II -induced aneurysm formation in apolipoprotein e-deficient mice. J. Vasc. Surg. 52, 159\u2013166 (2010).","journal-title":"J. Vasc. Surg."},{"key":"BFsrep35190_CR30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.gt.3302496","volume":"12","author":"K Miwa","year":"2005","unstructured":"Miwa, K. et al. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther. 12, 1109\u20131118 (2005).","journal-title":"Gene Ther."},{"key":"BFsrep35190_CR31","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","volume":"99","author":"IB Lobov","year":"2002","unstructured":"Lobov, I. B., Brooks, P. C. & Lang, R. A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. USA 99, 11205\u201311210 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep35190_CR32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet, P. Angiogenesis in health and disease. Nat. med. 9, 653\u2013660 (2003).","journal-title":"Nat. med."},{"key":"BFsrep35190_CR33","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1158\/0008-5472.CAN-07-1684","volume":"67","author":"CE Lewis","year":"2007","unstructured":"Lewis, C. E., De Palma, M. & Naldini, L. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res. 67, 8429\u20138432 (2007).","journal-title":"Cancer Res."},{"key":"BFsrep35190_CR34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/emmm.201302752","volume":"5","author":"AS Patel","year":"2013","unstructured":"Patel, A. S. et al. TIE2-expressing monocytes\/macrophages regulate revascularization of the ischemic limb. EMBO Mol. Med. 5, 858\u2013869 (2013).","journal-title":"EMBO Mol. Med."},{"key":"BFsrep35190_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0741-5214(05)80007-2","volume":"21","author":"DR Holmes","year":"1995","unstructured":"Holmes, D. R., Liao, S., Parks, W. C. & Thompson, R. W. Medial neovascularization in abdominal aortic aneurysms: A histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J. Vasc. Surg. 21, 761\u2013771 (1995).","journal-title":"J. Vasc. Surg."},{"key":"BFsrep35190_CR36","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/01.ATV.0000085631.76095.64","volume":"23","author":"K Saraff","year":"2003","unstructured":"Saraff, K. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 1621\u20131626 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep35190_CR37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nm0206-171","volume":"12","author":"BA Imhof","year":"2006","unstructured":"Imhof, B. A. & Aurrand-Lions, M. Angiogenesis and inflammation face off. Nat Med. 12, 171\u2013172 (2006).","journal-title":"Nat Med."},{"key":"BFsrep35190_CR38","doi-asserted-by":"crossref","first-page":"H2879","DOI":"10.1152\/ajpheart.91406.2007","volume":"294","author":"M Takahashi","year":"2008","unstructured":"Takahashi, M. et al. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: Roles of NF-\u03baB, p38, and reactive oxygen species. Am. J. Physiol. Heart. Circ. Physiol. 294, H2879\u2013H2888 (2008).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"BFsrep35190_CR39","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1172\/JCI38308","volume":"119","author":"BC Tieu","year":"2009","unstructured":"Tieu, B. C. et al. An adventitial IL-6\/MCP-1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 119, 3637\u20133651 (2009).","journal-title":"J Clin Invest."},{"key":"BFsrep35190_CR40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cvr\/cvs298","volume":"97","author":"T Saito","year":"2012","unstructured":"Saito, T. et al. Importance of endothelial NF-\u03baB signalling in vascular remodelling and aortic aneurysm formation. Cardiovasc. Res. 97, 106\u2013114 (2012).","journal-title":"Cardiovasc. Res."},{"key":"BFsrep35190_CR41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","volume":"20","author":"ME Pueyo","year":"2000","unstructured":"Pueyo, M. E. et al. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-\u03baB activation induced by intracellular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 20, 645\u2013651 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep35190_CR42","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/ATVBAHA.112.301006","volume":"33","author":"CS Moran","year":"2013","unstructured":"Moran, C. S. et al. Everolimus limits aortic aneurysm in the apolipoprotein e-deficient mouse by downregulating c-c chemokine receptor 2 positive monocytes. Arterioscler. Thromb. Vasc. Biol. 33, 814\u2013821 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep35190_CR43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2012.04.015","volume":"181","author":"SM Krishna","year":"2012","unstructured":"Krishna, S. M. et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am. J. Pathol. 181, 706\u2013718 (2012).","journal-title":"Am. J. Pathol."},{"key":"BFsrep35190_CR44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00015458.2009.11680364","volume":"109","author":"FA Lederle","year":"2009","unstructured":"Lederle, F. A. The natural history of abdominal aortic aneurysm. Acta. Chir. Belg. 109, 7\u201312 (2009).","journal-title":"Acta. Chir. Belg."},{"key":"BFsrep35190_CR45","first-page":"9","volume":"1","author":"RY Cao","year":"2010","unstructured":"Cao, R. Y., Amand, T., Ford, M. D., Piomelli, U. & Funk, C. D. The murine angiotensin II-induced abdominal aortic aneurysm model: Rupture risk and inflammatory progression patterns. Front. Pharmacol. 1, 9 (2010).","journal-title":"Front. Pharmacol."},{"key":"BFsrep35190_CR46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/CS20090372","volume":"118","author":"A Daugherty","year":"2010","unstructured":"Daugherty, A. et al. A. Angiotensin II infusion promotes ascending aortic aneurysms: Attenuation by ccr2 deficiency in apoe\u2212\/\u2212 mice. Clin. Sci. 118, 681\u2013689 (2010).","journal-title":"Clin. Sci."},{"key":"BFsrep35190_CR47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtcvs.2011.07.053","volume":"142","author":"CW Moehle","year":"2011","unstructured":"Moehle, C. W. et al. Bone marrow-derived MCP-1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J. Thorac. Cardiovasc. Surg. 142, 1567\u20131574 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFsrep35190_CR48","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","volume":"394","author":"L Boring","year":"1998","unstructured":"Boring, L., Gosling, J., Cleary, M. & Charo, I. F. Decreased lesion formation in CCR2\u2212\/\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394, 894\u2013897 (1998).","journal-title":"Nature."},{"key":"BFsrep35190_CR49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ni1309","volume":"7","author":"NV Serbina","year":"2006","unstructured":"Serbina, N. V. & Pamer, E. G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311\u2013317 (2006).","journal-title":"Nat. Immunol."},{"key":"BFsrep35190_CR50","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nri2415","volume":"8","author":"C Weber","year":"2008","unstructured":"Weber, C., Zernecke, A. & Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat. Rev. Immunol. 8, 802\u2013815 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFsrep35190_CR51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00280-014-2479-8","volume":"74","author":"D Mahalingam","year":"2014","unstructured":"Mahalingam, D. et al. Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma. Cancer Chemother. Pharmacol. 74, 77\u201384 (2014).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFsrep35190_CR52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/CIRCRESAHA.109.196154","volume":"104","author":"A Ahmed","year":"2009","unstructured":"Ahmed, A. et al. Angiopoietin-2 confers atheroprotection in apoe\u2212\/\u2212 mice by inhibiting LDL oxidation via nitric oxide. Circ. Res. 104, 1333\u20131336 (2009).","journal-title":"Circ. Res."},{"key":"BFsrep35190_CR53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","volume":"3","author":"NW Gale","year":"2002","unstructured":"Gale, N. W. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev. Cell. 3, 411\u2013423 (2002).","journal-title":"Dev. Cell."},{"key":"BFsrep35190_CR54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nsb880","volume":"10","author":"S Davis","year":"2003","unstructured":"Davis, S. et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10, 38\u201344 (2003).","journal-title":"Nat. Struct. Biol."},{"key":"BFsrep35190_CR55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2009.10.027","volume":"210","author":"J Golledge","year":"2010","unstructured":"Golledge, J. et al. Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm. Atherosclerosis. 210, 51\u201356 (2010).","journal-title":"Atherosclerosis."},{"key":"BFsrep35190_CR56","doi-asserted-by":"crossref","first-page":"e58481","DOI":"10.1371\/journal.pone.0058481","volume":"8","author":"SW Seto","year":"2013","unstructured":"Seto, S. W. et al. Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin ii-infused apolipoprotein-e (apoe\u2212\/\u2212) knockout mice. PLoS One. 8, e58481 (2013).","journal-title":"PLoS One."},{"key":"BFsrep35190_CR57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-10-298","volume":"10","author":"C Rush","year":"2009","unstructured":"Rush, C. et al. Whole genome expression analysis within the angiotensin ii-apolipoprotein e deficient mouse model of abdominal aortic aneurysm. BMC Genomics. 10, 298 (2009).","journal-title":"BMC Genomics."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep35190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35190","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep35190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:50:03Z","timestamp":1672887003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep35190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep35190"],"URL":"https:\/\/doi.org\/10.1038\/srep35190","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]},"assertion":[{"value":"25 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35190"}}